Cleared Traditional

K962161 - BAXTER NEBULIZER CAP MODEL 2D0868

K962161 is an FDA 510(k) clearance for BAXTER NEBULIZER CAP MODEL 2D0868, manufactured by Baxter Healthcare Corp. The device is a Class 2 Anesthesiology device with product code CAF cleared through the Traditional 510(k) pathway after a 72-day FDA review.

K962161 · Baxter Healthcare Corp · Anesthesiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Aug 1996
Decision
72d
Days
Class 2
Risk

K962161 is an FDA 510(k) clearance for the BAXTER NEBULIZER CAP MODEL 2D0868. Classified as Nebulizer (direct Patient Interface) (product code CAF), Class II - Special Controls.

Submitted by Baxter Healthcare Corp (Tarpon Springs, US). The FDA issued a Cleared decision on August 15, 1996 after a review of 72 days - a notably fast clearance cycle.

This device falls under the Anesthesiology FDA review panel, regulated under 21 CFR 868.5630 - the FDA anesthesiology and respiratory device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Baxter Healthcare Corp devices

FDA 510(k) Submission Details - K962161

510(k) Number K962161 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received June 04, 1996
Decision Date August 15, 1996
Days to Decision 72 days
Submission Type Traditional
Review Panel Anesthesiology (AN)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
68d faster than avg
Panel avg: 140d · This submission: 72d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

CAF Device Classification - Class 2, Special Controls

Product Code CAF Nebulizer (direct Patient Interface)
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 868.5630
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Anesthesiology devices follow this clearance model.

Regulatory Peers - CAF Nebulizer (direct Patient Interface)

All 367
Devices cleared under the same product code (CAF) and FDA review panel - the closest regulatory comparables to K962161.
SALTER LABS 8990 SERIES NEBULIZER
K962085 · Salter Labs · Aug 1996
PRONEB TURBO COMPRESSOR MODEL 38V0200
K962072 · Pari Holding Co. · Aug 1996
DHD ACE WITH MASK KIT
K961973 · Dhd Diemolding Healthcare Div. · Aug 1996
SALTERLABS 8960 SERIES NEBULIZER (8960/8961/8966/8984)
K961476 · Salter Labs · Jul 1996
HIGH FLOW ADJUSTABLE ENTRAINMENT NEBULIZER
K955104 · Automatic Liquid Packaging, Inc. · Jun 1996
WALKHALER PORTABLE COMPRESSOR MODEL 45F70
K960675 · Pari Holding Co. · May 1996